Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biomarkers for Efficacy and Toxicity”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableUnknownNCT03919539
What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for
Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity
Peking University People's Hospital 40
Not applicableLooking for participantsNCT04807114
What this trial is testing

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Who this might be right for
Lung Diseases, InterstitialNSCLCImmunotherapy
Universitaire Ziekenhuizen KU Leuven 70
Not applicableUnknownNCT04227886
What this trial is testing

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Who this might be right for
Rectal Neoplasm Malignant CarcinomaChemoradiotherapyNeoadjuvant Therapy+2 more
Fudan University 250
Not applicableLooking for participantsNCT06339255
What this trial is testing

Italian Observational Study on CAR-T Therapy for Lymphoma

Who this might be right for
Diffuse Low Grade B-Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma+1 more
Paolo Corradini 5,300